摘要:
The present invention features improved Compounds, especially (I) methods of identifying patients having Cancer using biomarkers (e.g., PDE3A, SLFN12 and/or CREB3Ll) that correlate with drug sensitivity and consequently treating a stratified patient population with an agent of the invention (e.g., Compounds 1-6 disclosed herein).
摘要:
Die vorliegende Anmeldung betrifft neue substituierte Indazole, Verfahren zu ihrer Herstellung, ihre Verwendung allein oder in Kombinationen zur Behandlung und/oder Prophylaxe von Krankheiten sowie ihre Verwendung zur Herstellung von Arzneimitteln zur Behandlung und/oder Prophylaxe von Krankheiten, insbesondere zur Behandlung und/oder Prophylaxe von Endometriose sowie Endometriose-assoziierter Schmerzen und anderer Endometriose-assoziierter Symptome wie Dysmenorrhoe, Dyspareunie, Dysurie und Dyschezie, von Lymphomen, Rheumatoider Arthritis, Spondyloarthritiden (insbesondere Spondyloarthritis psoriatica und Morbus Bechterew), Lupus erythematodes, Multipler Sklerosis, Makuladegeneration, COPD, Gicht, Fettlebererkrankungen, Insulinresistenz, Tumorerkrankungen und Psoriasis.
摘要:
The present application relates to novel combinations of at least two components, component A and component B: ⋅component A is an IRAK4-inhibiting compound of the formula (I) as defined herein, or a diastereomer, an enantiomer, a metabolite, a salt, a solvate or a solvate of a salt thereof; ⋅component B is a BTK-inhibiting compound, or a pharmaceutically acceptable salt thereof; and, optionally, ⋅one or more components C which are pharmaceutical products; in which one or two of the above-defined compounds A and B are optionally present in pharmaceutical formulations ready for simultaneous, separate or sequential administration, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of endometriosis, lymphoma, macular degeneration, COPD, neoplastic disorders and psoriasis.
摘要:
The invention relates to a novel 6-substituted indazoles with carboxamide side chains, method for the production thereof, to the use thereof alone or in combinations for treating and/or the prophylaxis of diseases and to the use thereof for producing medicaments for treating and/or the prophylaxis of diseases, in particular for treating and/or the prophylaxis of endometriosis, preventing lymphomas, macular degeneration, COPD and psoriasis.